Functional barrier polymers show low acute toxicity across dermal, oral, and inhalation routes, with no GHS hazard classifications reported. Dermal LD50 values exceed 2 g/kg in rats and rabbits, oral LD50 values range from >2 g/kg to 6.6 g/kg, and an inhalation study at 0.68 mg/L produced no deaths. Skin irritation and sensitization were generally absent, though undiluted copolyol forms caused slight to moderate irritation. A subchronic oral NOAEL of 1000 mg/kg/day was established for PEG-12 dimethicone. These data support a low hazard profile, but the absence of GHS classifications limits standardized risk communication.
The toxicology data should be interpreted as indicating low acute hazard, but the lack of GHS classifications means standardized hazard communication is incomplete. LD50 values consistently above 2 g/kg and NOAELs of 1000 mg/kg/day suggest minimal acute risk, yet the absence of harmonized classifications prevents direct comparison with regulatory hazard categories. The observed erythema at 2000 mg/kg in rabbits and increased fetal resorption sites in one rabbit study warrant attention, though they were not definitively causative. Formulators should rely on the specific toxicological endpoints rather than assume a universally benign profile.
Dermal exposure is the most material route, given the extensive irritation and sensitization testing, with no sensitization observed in multiple assays and only transient erythema at high doses. Oral exposure shows low toxicity, with LD50 values above 2 g/kg and a subchronic NOAEL of 1000 mg/kg/day. Inhalation exposure appears minimal, as a study at 0.68 mg/L caused no deaths. For occupational handling, dermal contact is the primary concern, especially with undiluted copolyol forms that caused slight to moderate irritation. These findings support low systemic risk under typical use, but high-dose dermal contact may cause transient irritation.
Handling measures should focus on minimizing dermal contact, particularly with undiluted copolyol forms that caused slight to moderate irritation. Standard personal protective equipment such as gloves and protective clothing is advisable, though the low acute toxicity suggests no extraordinary precautions are needed. Given the minimal inhalation hazard, respiratory protection is not indicated based on available data. For formulation, diluting copolyol ingredients may reduce irritation potential. The absence of GHS classifications means relying on empirical toxicological data for safety data sheets, and monitoring for local irritation during handling is prudent.
Before finalizing safety decisions, GHS hazard classifications should be obtained to enable standardized risk communication and regulatory alignment. Definitive NOAEL and LD50 values are missing for several related compounds, limiting dose-response interpretation. The teratogenicity signal in rabbits requires clarification to rule out reproductive toxicity. Chronic toxicity and carcinogenicity data are absent, and no exposure limits are established. These gaps are critical for regulatory submissions and for setting occupational exposure controls, as current evidence only supports low acute hazard without comprehensive chronic risk assessment.